To your first question, I don't feel an appropriate place to comment about CIDA, and working with...I mean, we have a WTO commitment, a WTO decision that Canada was part of. We have legislation that's not working. We put a lot of effort into seeing if it would work, and then having the experience to share here today. So that for me is a possibility, but it distracts from the fact that Canada still has a commitment and that this needs to be solved.
On the second question, we might work together. As I said, MSF does drug procurement in many countries. We're always looking for opportunities. We're looking for the best price, looking for quality drugs. We may get involved in a smaller level in Canada, but then we have to remember that we're an international organization. Right now 82% of our drugs are coming from India. We are trying to think laterally and look for other resources. That's why we're involved with patent issues. We have a commitment to our patients who are being treated now, and with second-line, sometimes the drug prices are from 12% to 50% more.
So indeed, we might do a partnership.